Literature DB >> 31101890

Consensus recommendations for the role and competencies of the EBMT clinical pharmacist and clinical pharmacologist involved in hematopoietic stem cell transplantation.

Claudia Langebrake1, Rick Admiraal2,3, Erik van Maarseveen3,4, Agnès Bonnin5, Tiene Bauters6.   

Abstract

Mesh:

Year:  2019        PMID: 31101890     DOI: 10.1038/s41409-019-0538-9

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  22 in total

1.  Towards evidence-based dosing regimens in children on the basis of population pharmacokinetic pharmacodynamic modelling.

Authors:  Rick Admiraal; Charlotte van Kesteren; Jaap Jan Boelens; Robbert G M Bredius; Dick Tibboel; Catherijne A J Knibbe
Journal:  Arch Dis Child       Date:  2013-12-19       Impact factor: 3.791

2.  Clinical pharmacists' interventions in a German university hospital.

Authors:  Claudia Langebrake; Heike Hilgarth
Journal:  Pharm World Sci       Date:  2010-01-19

Review 3.  Effectiveness of clinical pharmacy services: an overview of systematic reviews (2000-2010).

Authors:  Inajara Rotta; Teresa M Salgado; Maria Lara Silva; Cassyano J Correr; Fernando Fernandez-Llimos
Journal:  Int J Clin Pharm       Date:  2015-05-23

4.  Nationwide evaluation of day-to-day clinical pharmacists' interventions in German hospitals.

Authors:  Claudia Langebrake; Angela Ihbe-Heffinger; Katja Leichenberg; Sandra Kaden; Mareike Kunkel; Michael Lueb; Heike Hilgarth; Carina Hohmann
Journal:  Pharmacotherapy       Date:  2015-04       Impact factor: 4.705

Review 5.  JACIE: A 20 year-old voluntary body functioning worldwide.

Authors:  Meltem Kurt Yüksel; Osman İlhan
Journal:  Transfus Apher Sci       Date:  2018-04-18       Impact factor: 1.764

6.  Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis.

Authors:  Imke H Bartelink; Arief Lalmohamed; Elisabeth M L van Reij; Christopher C Dvorak; Rada M Savic; Juliette Zwaveling; Robbert G M Bredius; Antoine C G Egberts; Marc Bierings; Morris Kletzel; Peter J Shaw; Christa E Nath; George Hempel; Marc Ansari; Maja Krajinovic; Yves Théorêt; Michel Duval; Ron J Keizer; Henrique Bittencourt; Moustapha Hassan; Tayfun Güngör; Robert F Wynn; Paul Veys; Geoff D E Cuvelier; Sarah Marktel; Robert Chiesa; Morton J Cowan; Mary A Slatter; Melisa K Stricherz; Cathryn Jennissen; Janel R Long-Boyle; Jaap Jan Boelens
Journal:  Lancet Haematol       Date:  2016-10-13       Impact factor: 18.959

Review 7.  The evolution of stem-cell transplantation in multiple myeloma.

Authors:  Sarakshi Mahajan; Nidhi Tandon; Shaji Kumar
Journal:  Ther Adv Hematol       Date:  2018-03-05

8.  Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a multicentre, retrospective, pharmacodynamic cohort analysis.

Authors:  Rick Admiraal; Stefan Nierkens; Moniek A de Witte; Eefke J Petersen; Ger-Jan Fleurke; Luka Verrest; Svetlana V Belitser; Robbert G M Bredius; Reinier A P Raymakers; Catherijne A J Knibbe; Monique C Minnema; Charlotte van Kesteren; Jurgen Kuball; Jaap J Boelens
Journal:  Lancet Haematol       Date:  2017-03-16       Impact factor: 18.959

9.  Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis.

Authors:  Rick Admiraal; Charlotte van Kesteren; Cornelia M Jol-van der Zijde; Arjan C Lankester; Marc B Bierings; Toine C G Egberts; Maarten J D van Tol; Catherijne A J Knibbe; Robbert G M Bredius; Jaap J Boelens
Journal:  Lancet Haematol       Date:  2015-04-21       Impact factor: 18.959

Review 10.  Economic evaluations of clinical pharmacy services: 2006-2010.

Authors:  Daniel R Touchette; Fred Doloresco; Katie J Suda; Alexandra Perez; Stuart Turner; Yash Jalundhwala; Maria C Tangonan; James M Hoffman
Journal:  Pharmacotherapy       Date:  2014-03-19       Impact factor: 4.705

View more
  4 in total

1.  Chimeric Antigen Receptor T Cell Therapy Management and Safety: A Practical Tool From a Multidisciplinary Team Perspective.

Authors:  María Belen Marzal-Alfaro; Vicente Escudero-Vilaplana; Jose Luis Revuelta-Herrero; Roberto Collado-Borrell; Ana Herranz-Alonso; Maria Sanjurjo-Saez
Journal:  Front Oncol       Date:  2021-03-11       Impact factor: 6.244

Review 2.  Improved Therapeutic Approaches are Needed to Manage Graft-versus-Host Disease.

Authors:  Deborah S Hooker; Kristin Grabe-Heyne; Christof Henne; Peter Bader; Mondher Toumi; Stephen J Furniss
Journal:  Clin Drug Investig       Date:  2021-10-16       Impact factor: 2.859

Review 3.  The Past, Present, and Future of Clinically Applied Chimeric Antigen Receptor-T-Cell Therapy.

Authors:  Yuki Fujiwara; Toshiki Kato; Futoshi Hasegawa; Muha Sunahara; Yoshie Tsurumaki
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-09

4.  The Hematopoietic Cell Transplant Pharmacist: A Call to Action.

Authors:  Amber Clemmons
Journal:  Pharmacy (Basel)       Date:  2020-01-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.